2.4.3. Other Assessments
DISEASE, DISEASE, SYSTEMIC LUPUS ERYTHEMATOSUS, DISEASE PROGRESSION
Participants completed a questionnaire on sociodemographic and clinical data. Disease progression was assessed using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), with a range of 0–105 where a high score indicates a higher degree of disease activity [